A Solution to Blood Culture Contamination: Impacts on Patients, Antibiotic Stewardship, CLABSIs and The Bottom Line

• Recognize the downstream impacts of false-positive blood cultures with focus on antibiotic stewardship and prevention of patient harm.
• Understand the impacts of false-positive blood cultures on the Laboratory, ED and Inpatient units.
• Describe the impacts of false-positive blood cultures on publicly reported CLABSI events.
• Review intervention methods that have attempted to reduce blood culture contamination.
• Learn of an evidence-based technology solution that addresses blood culture diagnostic accuracy and clinical decision making.
• Learn about incentives and value adds available exclusively to Intalere members.

Hosted By:

• Pat Martin, Director, Laboratory Advisory Services, Intalere

Guest Speakers:

• Matt Stuckert, Vice President of Sales, Magnolia Medical Technologies
• Barb DeBaun, MSN, RN, CIC, Improvement Advisor, Cynosure Health

Live Webinar Date: 

Thursday, September 24, 2020 @ 10:00 am (PT)
To register for one of the live webinar, click one of the hyperlinks above.  After registration, you will receive a confirmation email containing information about joining the webinar.

We look forward to the opportunity to partner with you in your mission to eliminate blood culture contamination and improve sepsis testing accuracy to improve patient safety, drive antimicrobial stewardship, prevent unnecessary reporting of false-positive CLABSIs and significantly reduce hospital costs.